Related Experiment Video
Updated: Feb 14, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Emerging Biomarkers in Cutaneous Melanoma
Anna Eisenstein1, Estela Chen Gonzalez1, Rekha Raghunathan1
1Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA, 02118, USA.
Identifying aggressive melanoma early is key. New biomarkers, including proteins, genetic mutations, and circulating DNA, help diagnose melanoma, predict progression, and monitor therapy response for better patient outcomes.
Area of Science:
- Oncology
- Dermatology
- Biomarker Research
Background:
- Early identification of aggressive melanoma is crucial for effective treatment.
- Advances in targeted and immune therapies necessitate better methods for predicting disease progression and treatment response.
- Biomarkers are essential for diagnosing melanoma and guiding therapeutic strategies.
Purpose of the Study:
- To review promising biomarkers for earlier melanoma identification and improved treatment.
- To highlight biomarkers that aid in predicting disease progression and response to therapy.
- To discuss various forms of biomarkers, from tissue-based to circulating markers.
Main Methods:
- Review of conventional tissue markers (e.g., tumor depth) for melanoma staging.
- Description of protein biomarkers for diagnostic and prognostic information.
- Discussion of genetic mutations, microRNA, and epigenetic modifications.
- Review of emerging serologic biomarkers, including circulating melanoma cells and exosomes.
Main Results:
- Biomarkers encompass protein expression, genetic mutations, and circulating DNA.
- Protein biomarkers offer diagnostic and prognostic value.
- Genetic mutations, microRNA, and epigenetic modifications provide therapeutic and prognostic insights.
- Serologic biomarkers like circulating melanoma cells and exosomes show emerging potential.
Conclusions:
- Biomarkers are vital for earlier detection and improved management of aggressive melanoma.
- A diverse range of biomarkers, including novel serologic markers, are being investigated.
- Continued research into biomarkers will enhance personalized treatment strategies for melanoma patients.
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
Applications of GIS: Disaster Management and Emergency Response
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Bystander Effect
The de Broglie Wavelength

